Cost-effectiveness of a nurse-based intervention (AIMS) to improve adherence among HIV-infected patients: Design of a multi-centre randomised controlled trial

BMC Health Services Research

Volumn 13, Issue 1, 2013, Pages

  Oberjé, Edwin ^a   De Bruin, Marijn ^a   Evers, Silvia ^b   Viechtbauer, Wolfgang ^b   Nobel, Hans Erik ^c   Schaalma, Herman ^b   McCambridge, Jim ^d   Gras, Luuk ^e   Tousset, Eric ^f   Prins, Jan ^c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e STICHTING HIV MONITORING   (Netherlands)

^f AARDEX Group Ltd   (Belgium)

Author keywords

Adherence; AIMS; Economic evaluation; HIV; Intervention; Randomised controlled trial

Indexed keywords

ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COUNSELING; ECONOMICS; HEALTH PROMOTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICATION COMPLIANCE; MULTICENTER STUDY; NETHERLANDS; NURSE ATTITUDE; NURSING; RANDOMIZED CONTROLLED TRIAL; SELF CARE;

COST-BENEFIT ANALYSIS; COUNSELING; HEALTH PROMOTION; HIV INFECTIONS; HUMANS; MEDICATION ADHERENCE; NETHERLANDS; NURSE'S ROLE; SELF CARE;

EID: 84880181520     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-13-274     Document Type: Article

References (38)

1. Antiretroviral treatment of adult HIV infection. Thompson MA, Aberg JA, Cahn P, Montaner JS, Rizzardini G, Telenti A, Gatell JM, Günthard HF, Hammer SM, Hirsch MS, J Am Med Assoc 2010 304 3 321 333 10.1001/jama.2010.1004
2. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: A collaborative analysis of 14 cohort studies. Antiretroviral TCC, Lancet 2008 372 9635 293 18657708
3. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. Das M, Chu PL, Santos G, Scheer S, Vittinghoff E, McFarland W, Colfax GN, PLoS One 2010 5 6 11068 10.1371/journal.pone.0011068 20548786
4. Prevention of HIV-1 infection with early antiretroviral therapy. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztjen B, Pilotto JHS, N Engl J Med 2011 365 6 493 505 10.1056/NEJMoa1105243 21767103
5. Relation between HIV viral load and infectiousness: A model-based analysis. Wilson DP, Law MG, Grulich AE, Cooper DA, Kaldor JM, Lancet 2008 372 9635 314 320 10.1016/S0140-6736(08)61115-0 18657710
6. Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Bangsberg DR, Clin Infect Dis 2006 43 7 939 941 10.1086/507526 16941380
7. The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. Lima VD, Harrigan R, Bangsberg DR, Hogg RS, Gross R, Yip B, Montaner JSG, J Acquir Immune Defic Syndr 2009 50 5 529 536 10.1097/QAI.0b013e31819675e9 19223785
8. HIV treatment adherence, drug resistance, virologic failure: Evolving concepts. Nachega BJ, Marconi CV, Van Zyl UG, Gardner ME, Preiser W, Hong YS, Mills JE, Gross R, Infect Disord Drug Targets 2011 11 2 167 174 10.2174/187152611795589663 21406048
9. A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. Howard AA, Arnsten JH, Lo Y, Vlahov D, Rich JD, Schuman P, Stone VE, Smith DK, Schoenbaum EE, AIDS 2002 16 16 2175 2182 10.1097/00002030-200211080-00010 12409739
10. Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: The GEEMA study. Knobel H, Alonso J, Casado JL, Collazos J, González J, Ruiz I, Kindelan JM, Carmona A, Juega J, Ocampo A, AIDS 2002 16 4 605 10.1097/00002030-200203080-00012 11873004
11. Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors. Knobel H, Guelar A, Carmona A, Espona M, González A, López-Colomés JL, Saballs P, Gimeno JL, Diez A, AIDS Patient Care STDS 2001 15 4 193 199 10.1089/10872910151133729 11359661
12. Standard care quality determines treatment outcomes in control groups of HAART-adherence intervention studies: Implications for the interpretation and comparison of intervention effects. De Bruin M, Viechtbauer W, Hospers HJ, Schaalma HP, Kok G, Health Psychol 2009 28 6 668 19916634
13. Standard care impact on effects of highly active antiretroviral therapy adherence interventions: A meta-analysis of randomized controlled trials. De Bruin M, Viechtbauer W, Schaalma HP, Kok G, Abraham C, Hospers HJ, Arch Intern Med 2010 170 3 240 10.1001/archinternmed.2009.536 20142568
14. Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. Goldie SJ, Paltiel AD, Weinstein MC, Losina E, Seage G 3rd, Kimmel AD, Walensky RP, Sax PE, Freedberg KA, Am J Med 2003 115 8 632 10.1016/j.amjmed.2003.07.007 14656616
15. Clinical and economic outcomes of nonadherence to highly active antiretroviral therapy in patients with human immunodeficiency virus. Munakata J, Benner JS, Becker S, Dezii CM, Hazard EH, Tierce JC, Med Care 2006 44 10 893 899 10.1097/01.mlr.0000233679.20898.e9 17001259
16. Clinical and economic implications of non-adherence to HAART in HIV infection. Scalera A, Bayoumi AM, Oh P, Risebrough N, Shear N, Dis Manag Health Out 2002 10 2 85 91 10.2165/00115677-200210020-00003
17. Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. Mannheimer S, Matts J, Telzak E, Chesney M, Child C, Wu A, MacArthur RD, Matts J, Friedland G, AIDS Care 2005 17 1 10 22 10.1080/09540120412331305098 15832830
18. Electronic monitoring-based counseling to enhance adherence among HIV-infected patients: A randomized controlled trial. De Bruin M, Hospers HJ, Van Breukelen GJP, Kok G, Koevoets WM, Prins JM, Health Psychol 2010 29 4 421 20658830
19. Efficacy of antiretroviral therapy adherence interventions: A research synthesis of trials, 1996 to 2004. Amico KR, Harman JJ, Johnson BT, J Acquir Immune Defic Syndr 2006 41 3 285 297 10.1097/01.qai.0000197870.99196.ea 16540929
20. Antiretroviral adherence interventions: Translating research findings to the real world clinic. Simoni JM, Amico KR, Smith L, Nelson K, Curr HIV/AIDS Rep 2010 7 1 44 51 10.1007/s11904-009-0037-5 20425057
21. Strategies for promoting adherence to antiretroviral therapy: A review of the literature. Simoni JM, Amico KR, Pearson CR, Malow R, Curr Infect Dis Rep 2008 10 6 515 521 10.1007/s11908-008-0083-y 18945394
22. Adherence to HAART: A systematic review of developed and developing nation patient-reported barriers and facilitators. Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, Wilson K, Buchan I, Gill CJ, Cooper C, PLoS Med 2006 3 11 438 10.1371/journal.pmed.0030438 17121449
23. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: A systematic literature review and meta-analysis. Demonceau J, Ruppar T, Kristanto P, Hughes DA, Fargher E, Kardas P, De Geest S, Dobbels F, Lewek P, Urquhart J, Drugs 2013 73 545 562 10.1007/s40265-013-0041-3 23588595
24. Managed problem solving for antiretroviral therapy Adherence: A randomized Trial. Gross R, Bellamy SL, Chapman J, Han X, O'Duor J, Palmer SC, Houts PS, Coyne JC, Strom BL, JAMA Intern Med 2013 173 4 300 306 10.1001/jamainternmed.2013.2152 23358784
25. Effects of eHealth interventions on medication adherence: A systematic review of the literature. Linn AJ, Vervloet M, Van Dijk L, Smit EG, Van Weert JC, J Med Internet Res 2011 13 4 10.2196/jmir.1519
26. Criteria for evaluating evidence on public health interventions. Rychetnik L, Frommer M, Hawe P, Shiell A, J Epidemiol Community Health 2002 56 2 119 127 10.1136/jech.56.2.119 11812811
27. Closing the gap between research and practice: An overview of systematic reviews of interventions to promote the implementation of research findings. Bero LA, Grilli R, Grimshaw JM, Harvey E, Oxman AD, Thomson MA, BMJ 1998 317 7156 465 468 10.1136/bmj.317.7156.465 9703533
28. Cost-effectiveness of an intervention to improve adherence to antiretroviral therapy in HIV-infected patients. Freedberg KA, Hirschhorn LR, Schackman BR, Wolf LL, Martin LA, Weinstein MC, Goldin S, Paltiel AD, Katz C, Goldie SJ, J Acquir Immune Defic Syndr 2006 43 113 S118 10.1097/01.qai. 0000248334.52072.25 17133193
29. Drummond MF, Sculpher MJ, Torrance GW, O'brien BJ, Stoddart GL, Methods for the economic evaluation of health care programmes USA: Oxford University Press 2005
30. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JAC, BMJ 2011 343 5928 10.1136/bmj.d5928 22008217
31. Theory-and evidence-based intervention to improve adherence to antiretroviral therapy among HIVInfected patients in the Netherlands: A pilot study. De Bruin MD, Hospers H, Borne HWVD, Kok G, Prins J, AIDS Patient Care STDS 2005 19 6 384 394 10.1089/apc.2005.19.384 15989434
32. Effect of adherence to newly initiated antiretroviral therapy on plasma viral load. Gross R, Bilker WB, Friedman HM, Strom BL, AIDS 2001 15 16 2109 2117 10.1097/00002030-200111090-00006 11684930
33. Estimation of the comparative therapeutic superiority of QD and BID dosing regimens, based on integrated analysis of dosing history data and pharmacokinetics. Comté L, Vrijens B, Tousset E, Gérard P, Urquhart J, J Pharmacokinet Pharmacodyn 2007 34 4 549 558 10.1007/s10928-007- 9058-0 17497202
34. Implementation intentions and goal achievement: A metaanalysis of effects and processes. Gollwitzer PM, Sheeran P, Adv Exp Soc Psychol 2006 38 69 119
35. Standardisation of costs: The dutch manual for costing in economic evaluations. Oostenbrink JB, Koopmanschap MA, Rutten FFH, PharmacoEconomics 2002 20 7 443 454 10.2165/00019053-200220070-00002 12093300
36. The estimation of a preference-based measure of health from the SF-12. Brazier JE, Roberts J, Med Care 2004 42 9 851 859 10.1097/01.mlr.0000135827. 18610.0d 15319610
37. A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Ware JE Jr, Kosinski M, Keller SD, Med Care 1996 34 3 220 233 10.1097/00005650-199603000-00003 8628042
38. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. Schulz KF, Altman DG, Moher D, BMC Med 2010 8 1 18 10.1186/1741-7015-8-18 20334633